Jacob D. Johnson

Assessment and Continued Validation of the Malaria SYBR Green I-Based Fluorescence Assay for Use in Malaria Drug Screening

Jacob D. Johnson, Richard A. Dennull, Lucia Gerena et al. · Antimicrobial Agents and Chemotherapy · 2007 · 374 citations · Full text

Medicine, Pharmacology, Biopharmaceutics +14

Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine

Meera Venkatesan, Nahla B. Gadalla, Kasia Stepniewska et al. · American Journal of Tropical Medicine and Hygiene · 2014 · 304 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17

The Role of Pfmdr1 and Pfcrt in Changing Chloroquine, Amodiaquine, Mefloquine and Lumefantrine Susceptibility in Western-Kenya P. falciparum Samples during 2008–2011

Fredrick Eyase, Hoseah M. Akala, Luiser A. Ingasia et al. · PLoS ONE · 2013 · 103 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Genetics +15

Calcium mobilization and Rac1 activation are required for VCAM-1 (vascular cell adhesion molecule-1) stimulation of NADPH oxidase activity

Joan M. Cook‐Mills, Jacob D. Johnson, Tracy L. Deem et al. · Biochemical Journal · 2004 · 102 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Use of the NP-40 Detergent-Mediated Assay in Discovery of Inhibitors of β-Hematin Crystallization

Rebecca D. Sandlin, Melissa D. Carter, Patricia Lee et al. · Antimicrobial Agents and Chemotherapy · 2011 · 101 citations

Medicine, Biochemistry, Pharmacology +15